Whiting Samuel 4
4 · Tempest Therapeutics, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Whiting Samuel
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-03+100,000→ 100,000 totalExercise: $4.66Exp: 2034-01-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]These stock options vest in a series of 48 equal monthly installments measured from January 3, 2024, subject to the Reporting Person's continued service.